Navigation Links
Tria Beauty, Inc. Announces Partnership with Jenny McCarthy
Date:12/5/2012

DUBLIN, Calif., Dec. 5, 2012 /PRNewswire/ -- Today, Tria Beauty, Inc. announced its partnership with actress, Jenny McCarthy, on behalf of their Hair Removal Laser.  The Tria Hair Removal Laser is the first and only FDA-cleared laser available for at-home hair removal.  Under this new partnership, Ms. McCarthy will be collaborating with Tria for various public relations and marketing campaigns. 

"Who wants to worry about unwanted hair, especially in my line of work where I am constantly in front of the camera or attending events," stated Ms. McCarthy. "I was instantly drawn to the ease and convenience of the Tria Hair Removal Laser and the fact that it offered professional and permanent results in the comfort of your own home.  The thought of never needing to shave or wax again sounded like a dream come true." 

Tria is delighted to make life easier for Ms. McCarthy as she flawlessly juggles her life as a mother, actress, host and best-selling author. This past summer, she hosted the NBC reality television series, "Love in the Wild" and recently released her latest book, Bad Habits: Confessions of a Recovering Catholic.  Next up, she will return to Times Square for ABC's "New Year's Rockin' Eve" with Ryan Seacrest, and she will launch her own late night talk show on VH1 in February. With such a busy schedule, Tria's hair removal system is an expedient alternative to in-office treatments or hours spent waxing and shaving. 

"We were excited to learn that Ms. McCarthy is as much of a fan of the Tria Hair Removal Laser as Tria Beauty is of her," stated Tim Bunch, VP/General Manager, North American Marketing, Tria Beauty, Inc.  "We are happy to welcome Ms. McCarthy to the Tria Beauty family, as she embodies our brand personality – intelligent, confident and trustworthy."

About Tria Beauty, Inc.
Tria Beauty, Inc. creates light-based skin care and at-home laser hair remov
'/>"/>

SOURCE Tria Beauty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2. UBM Canon Announces its New Medical Technology Seminar Series
3. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
4. Perrigo Company Announces The Appointment Of Industry Veteran To Executive Vice President And General Manager, Rx
5. Ultra Clean Announces Participation in the Midtown CAP Summit Investor Conference
6. MetaStat Announces Presentations at the 2012 San Antonio Breast Cancer Symposium
7. Young Innovations Announces Definitive Agreement to be Acquired by Linden Capital Partners
8. ObeTherapy Announces the Publication of Results Obtained with one of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes
9. GDS International Announces "Industry Leader of the Year" Award at its Fourth Annual European Pharmaceutical Drug Discovery Summit
10. Elbit Imaging Ltd. Announces InSightecs ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
11. DenMat Announces Signing a Purchase Agreement to Acquire PeriOptix Inc., Leading Provider of Magnification and Illumination Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015 Mettler-Toledo International Inc. (NYSE: ... Provided below are the highlights: , Sales ... with the prior year. Reported sales decreased 4% as ... , Net earnings per diluted share as reported ... period. Adjusted EPS was $2.80 , an increase ...
(Date:7/30/2015)...  EP Global Communications, Inc. (Public OTC: EPGL) announced today ... Company about discussing EPGL,s electronic contact lens technologies.  ... 3, 2015.  Novartis CEO Joe Jimenez ... electronic contact lens market could be worth tens ... years.  Novartis partnered with Google in 2014 to ...
(Date:7/30/2015)... 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the second quarter ending June 30, 2015. ... across the organization.  We are excited to be near ... trial ever conducted with topline results expected in the ... Officer, PTC Therapeutics, Inc. "Translarna is now commercially available ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10
... Fibrosis Society Conference, MONMOUTH JUNCTION, N.J., June ... a Phase II clinical trial on its lead,investigational ... being developed for the treatment of cystic fibrosis ... bacterium Pseudomonas,aeruginosa. The Phase II data indicated that ...
... June 12 Genetic,Immunity, a US/Hungarian clinical-stage Company focused ... amplification, announced,today that the Company will be presenting at ... 2008 at the San Diego Convention Center,in San Diego, ... Lisziewicz, is scheduled to present at the following times:, ...
Cached Medicine Technology:Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 2Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 3Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 4Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 5Genetic Immunity to Present at 2008 BIO International Convention 2Genetic Immunity to Present at 2008 BIO International Convention 3
(Date:7/31/2015)... ... July 31, 2015 , ... Healthpointe , ... newly redesigned website at Healthpointe.net. The new website will feature a sleek and ... redesign serves to provide smoother interactions between patients and the Healthpointe clinics and ...
(Date:7/31/2015)... ... July 31, 2015 , ... Eldermark Software, ... LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies whitepaper. The whitepaper ... care providers understand the benefits of using medication management technologies . ...
(Date:7/31/2015)... ... ... According to WFLA on July 16th, Sarasota has seen at ... Thricefold deaths have held steady over the last “couple of months” according to WFLA. ... was spurred by the crackdown of prescription painkillers. Many users who were addicted to ...
(Date:7/31/2015)... ... July 31, 2015 , ... ZH Healthcare announces a new cloud based service ... Health IT as a Service (HITaaS) is a Healthcare dedicated cloud based service that ... , HITaaS manages all aspects of infrastructure, security, runtime, middleware, OS, virtualization, ...
(Date:7/31/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) , ... July ... ... delivered the 100th baby at Beaumont Hospital's Karmanos Center for Natural Birth ... for expectant mothers looking for a safe natural childbirth experience. With nurses and ...
Breaking Medicine News(10 mins):Health News:Healthpointe Announces Newly Redesigned Website 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4
... patient lying in a vegetative state for over 3 years ... assuage a spell of restlessness//. This pill will hit the ... name of this sleeping pill, will be clinically tested on ... out its potential to temporarily awaken people out of coma. ...
... 15% of Americans were suffered, was caused by distinctly ... little left// to do but to suffer in silence. ... their lives miserable, limiting some of their day-to-day activities. ... treatments is lifestyle modification instead of taking variety of ...
... toll rising to over 3500 and an incalculable number of ... Indonesia struggles// to cope with the injured and the dead. ... south of the city of Yogyakarta which is near the ... night. The earthquake left the city in shambles, cutting off ...
... some alarming world statistics regarding the use of tobacco amongst ... year olds consume tobacco and its products. , ,These ... World Health Organization's World No Tobacco Day; on May 31st. ... in any form or disguise,' conveying cigarette smoking in any ...
... a major factor causing health concerns among both the pregnant ... found that pregnant working// mothers who undergo a lot of ... that these children were five ounces lighter than the average ... in case pregnant smokers. These pregnant mothers put themselves through ...
... the Uganda AIDS Commission, Kihumuro Apuuli, and the envisaged ... , which is extremely crucial to extend their lives. ... ,Uganda has not been able to augment the annual ... percent, formerly conceived by the African heads of state ...
Cached Medicine News:Health News:Silence Puts Comfort For Digestive Syndrome 2Health News:Indonesian Earthquake – Story of Destruction, Death and Disease 2
... Quick & Easy Adjustment Of Blade Separation ... And Patient Comfort (Unlike Spring Action Speculum ... The Blades. No Laborious, Tedious, Slow Screw ... , ,Available In Either Solid Blade Or ...
... Special Low-profile Hourglass Jaw Design ... Through A Minimal Incision.,Mirror Polished Blades ... Acting Handle Mechanism Offers Control Over ... Prevent The Lens From Tilting During ...
... The 0.1mm Pierce Tip Opening ... Flap, Without The Need For A Separate Cystotome. ... Grasping Positions Without Elevating The Incision.,The Distal Jaws ... Blades Help To Prevent Inadvertent Pick Up Of ...
2.5V Halogen source, fiber-optic delivery, 3X magnification, pocket-sized....
Medicine Products: